Compare Abeona Therapeutics Inc (ABEO) vs Digital Realty Trust, Inc. (DLR) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs Digital Realty Trust, Inc. — how do they compare? Abeona Therapeutics Inc trades at $6.79 (market cap $373.32M), while Digital Realty Trust, Inc. trades at $176.09 (market cap $64.71B). The key difference: Digital Realty Trust, Inc. is far larger — about 173.3× Abeona Therapeutics Inc's market cap, and Digital Realty Trust, Inc. pays a 2.79% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | DLR | |
|---|---|---|
Market Cap | $373.32M | $64.71B |
Sector | Health | Real Estate |
52-Week High | $7.23 | $203.91 |
52-Week Low | $4.17 | $147.93 |
Enterprise Value | $228.22M | $82.23B |
Dividend Yield | — | 2.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
DLR trades at $174.9, up 0.92% today, with a bearish technical signal but strong analyst buy consensus. The stock shows robust revenue growth, with 2025 revenue at $6.11B and net income margin of 21.73%, though valuation ratios like P/E of 46.07 appear elevated. Recent news highlights a $7.8B data center acquisition from Blackstone, expanding its hyperscale portfolio amid AI-driven demand.
Outlook remains positive with a consensus price target of $219.08, but risks include high debt levels, execution challenges from recent acquisitions, and competitive pressures. The stock offers growth exposure to data center infrastructure, supported by institutional confidence, yet investors should weigh valuation concerns against expansion potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Digital Realty Trust, Inc.
Digital Realty owns and operates nearly 300 data centers worldwide. It has more than 35 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to cold shells, where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has de-emphasized cold shells and now primarily provides higher-level service to tenants, which outsource their related IT needs to Digital. Digital Realty has also moved more into the co-location business, increasingly serving enterprises and facilitating network connections. Digital Realty operates as a real estate investment trust.
Read more on DLR →
